Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in rats

European Journal of Pharmacology

Volumn 443, Issue 1-3, 2002, Pages 105-111

  Picada, Jaqueline N ^a   Schröder, Nadja ^b   Izquierdo, Ivan ^a,c   Henriques, João Antônio Pêgas ^a   Roesler, Rafael ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Apomorphine; Behavior; Dopamine; Memory; Oxidative stress; Parkinson's disease

Indexed keywords

8 OXOAPOMORPHINE SEMIQUINONE; APOMORPHINE; MORPHINE DERIVATIVE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG OXIDATION; FEMALE; HABITUATION; LONG TERM MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY;

EID: 0037123825     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01553-4     Document Type: Article

References (48)

1. Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease
2. Determination of apomorphine in rat plasma and brain by high-performance liquid chromatography with electrochemical detection
3. Biochemical and toxicological properties of the oxidation products of catecholamines
4. Sensory and cognitive functions of the basal ganglia
5. Potent, hydroxyl-radical-scavenging effect of apomorphine with iron and dopamine perfusion in rat striatum
6. Apomorphine for motor fluctuations and freezing in Parkinson's disease
7. Melanin biosynthesis from dopamine: II. A mass spectrometric and collisional spectroscopic investigation
8. The up- and down method for the determination of nociceptive thresholds in rats
9. Memory disruption in rats with nigral lesions induced by MPTP: A model for early Parkinson's disease amnesia
10. The effect of amantadine, L-dopa, (plus)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response
11. Increased levels of hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study
12. Pharmacology and neurochemistry of apomorphine
13. Cholinergic and dopaminergic agents which inhibit a passive avoidance response attenuate the paradigm-specific increases in NCAM syalilation state
14. Nefiracetam (DM-9384) reverses apomorphine-induced amnesia of a passive avoidance response: Delayed emergence of the memory retention effects
15. Apoptosis, neurotrophic factors and neurodegeneration
16. Cognitive deficits in Parkinson's disease
17. Oxidative stress and antioxidant therapy in Parkinson's disease
18. Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants
19. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
20. Long-term cognitive impairment in MPTP-treated rhesus monkeys
21. Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage
22. Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction
23. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
24. Cognitive and motor functioning in Parkinson disease subjects with and without questionable dementia
25. Oxidative stress: A role in the pathogenesis of Parkinson's disease
26. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
27. Motor response following repeated apomorphine administration is reduced in Parkinson's disease
28. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss
29. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine
30. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
31. Opposite effects induced by low and high doses of apomorphine on passive avoidance learning in mice
32. Sequential role of hippocampus and amygdala, entorhinal cortex and parietal cortex in formation and retrieval of memory for inhibitory avoidance in rats
33. Oxidative mechanisms in nigral cell death in Parkinson's disease
34. Levodopa neurotoxicity: Experimental studies versus clinical relevance
35. Dose finding in the Ames Salmonella assay
36. Toxic and protective effects of L-dopa on mesencephalic cell cultures
37. Toxic effects of L-DOPA on mesencephalic cell cultures: Protection with antioxidants
38. Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans
39. Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys
40. Memory-enhancing treatments do not reverse the impairment of inhibitory avoidance retention induced by NMDA receptor blockade
41. Guanosine impairs inhibitory avoidance performance in rats
42. Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects
43. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
44. Oxidative reactions and schizophrenia: A review-discussion
45. Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease
46. Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat
47. The enigma of neuromelanin in Parkinson's disease substantia nigra